Puma Biotechnology Inc (PBYI)

SG&A Expenses

$71.38M

TTM · Period ending: · USD

PBYI logo

PBYI SG&A Expenses

Latest reported$71.38M
PBYI TTM SG&A Expenses ($14.08K → $71.38M)
High-resolution chart · PNG

PBYI sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Puma Biotechnology Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
71,379,000
72,241,000
71,209,000
69,850,000
69,687,000
76,250,000
80,609,000
83,773,000
89,082,000
88,058,000
88,794,000
93,649,000
95,434,000
92,062,000
89,978,000
87,401,000
89,524,000
108,358,000
116,194,000
122,338,000
125,852,000
115,789,000
118,488,000
119,956,000
121,758,000
125,938,000
140,501,000
151,427,000
148,527,000
155,135,000
146,237,000
136,137,000
140,126,000
124,920,000
106,719,000
92,319,000
73,852,000
61,188,000
53,826,000
46,926,000
41,713,000
34,980,000
31,812,000
30,312,000
25,370,000
23,742,000
19,396,000
14,279,000
12,675,000
11,038,000
9,813,000
20,630,000
26,392,241
25,827,118
24,761,744
10,951,549
3,260,074
1,561,509
333,766
349,599
19,036
18,162
15,976
13,650
13,755
15,526
16,836
15,773
16,433
15,599
14,083
11,834
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.